CL
PTCT icon

Choreo LLC’s PTC Therapeutics PTCT Stock Holding History

Choreo LLC’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,767
Closed -$325K – 1773
2026
Q1 		$325K Buy
4,767
+583
+14% +$41.3K ﹤0.01% 1199
2025
Q4 		$319K Sell
4,184
-7,548
-64% -$549K ﹤0.01% 1186
2025
Q3 		$720K Buy
11,732
+41
+0.4% +$2.14K 0.01% 747
2025
Q2 		$571K Sell
11,691
-356
-3% -$16.9K 0.01% 830
2025
Q1 		$614K Buy
12,047
+86
+0.7% +$4.29K 0.01% 743
2024
Q4 		$541K Buy
11,961
+240
+2% +$10.3K 0.01% 865
2024
Q3 		$423K Buy
11,721
+295
+3% +$9.88K 0.01% 998
2024
Q2 		$356K Buy
11,426
+452
+4% +$14.6K 0.01% 998
2024
Q1 		$319K Buy
+10,974
New +$307K 0.01% 515

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Choreo LLC's PTCT Position: Q2 2026 in Review

Choreo LLC sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 4,767 shares — an estimated $325K sold.

Choreo LLC first reported a position in PTCT in Q1 2024 and held it in 9 quarters. The position peaked at $720K in Q3 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Choreo LLC reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Choreo LLC sold 4,767 PTC Therapeutics shares in Q2 2026, an estimated $325K.
  • Choreo LLC first reported a position in PTC Therapeutics in Q1 2024 and held it in 9 quarters.
  • Choreo LLC's PTC Therapeutics position peaked at $720K in Q3 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.